Major Contributions


  • Role of cytochrome P450-derived hyperpolarizing factors (EDHF) in endothelium-dependent vasodilatation in human, and consequences of its pharmacological restoration in cardio-metabolic diseases (PMID: 20083732 22412088 26022136)
  • Endothelial protective effects and reduction of heart failure by tyrosine phosphatase 1B inhibition (PMID: 22446161 17101854 24760754 27059805 29569957)
  • Dopamine and endothelial dysfunction in autosomal dominant polycystic kidney disease (PMID: 25029430)
  • Endothelial impact of antiphosphospholipid syndrome and thrombotic thrombocytopenic purpura (PMID: 25047402 27501520)


Heart Failure

  • Beneficial effects of pharmacological heart rate reduction in heart failure (PMID:14981003 22075752)
  • Aldosterone signaling in heart failure (PMID: 26902493 29061727)
  • Treatment of heart failure by localized slow delivery of angiogenic or lymphangiogenic growth factors (PMID:21824923 26933083)
  • Role of cardiac lymphatics and therapeutic lymphangiogenesis in myocardial infarction and heart failure (PMID: 26933083)



Endothelium, Valvulopathy
& Heart Failure

RĂ©alisation Internet Bordeaux.

Contact Us

Legal mentions